Clinical Trial Update: Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study

View source ↗

Summary

A US-based observational lymphoma registry sponsored by Celgene has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Celgene | Conditions: Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse | Status: TERMINATED